Dror Seliktar | Biomaterials & Regenerative Medicine

Dror Seliktar, PhD
Associate Professor
Department of Biomedical Engineering

Office: Silver 168
Phone: +972(4)8294805
Contact: dror@bm.technion.ac.il

Education/Positions

2011 – Present

Visiting Associate Professor – Nanotechnology Institute, National University of Singapore (NUS)

2009 – Present

Associate Professor – Department of Biomedical Engineering, Technion

2002 – 2009

Lecturer & Senior Lecturer – Department of Biomedical Engineering, Technion

2001 – 2002

Visiting Research Scholar – Samuel Lunenfeld Institute, Mount Sinai Hospital, University of Toronto

2000 – 2002

NSF International Postdoctoral Fellow – Department of Materials, ETH and University of Zürich

1994 – 2000

Ph.D. in Bioengineering – Department of Biomedical Engineering, Georgia Institute of Technology

1994 – 2000

M.Sc. in Mechanical Engineering – Department of Mechanical Engineering, Georgia Institute of Technology

1990 – 1994

B.Sc. (Summa cum Laude) in Mechanical Engineering – Department of Mechanical Engineering, Drexel University

More about Dr. Seliktar

Dr. Dror Seliktar is an associate professor on the Technion’s Faculty of Biomedical Engineering and a visiting associate professor in the Nanotechnology Institute, National University of Singapore. Dr. Seliktar earned his master’s and PhD degrees in mechanical engineering and biomedical engineering, respectively, from Georgia Tech. He previously received his bachelor’s degree in mechanical engineering from Drexel University in 1994. After earning his PhD, he was awarded a two-year post-doctoral appointment at the Swiss Federal Institute of Technology in Zurich sponsored by the United States National Science Foundation.

Seliktar’s primary area of interest is in the field of tissue engineering and regenerative medicine with an emphasis on hydrogel biomaterials and biomechanics. His academic research focuses specifically on novel hydrogel biomaterials for tissue engineering, regulation of morphogenesis via physical properties in 3-D culture, and mechanobiology in tissue engineering. Seliktar’s applied research in tissue regeneration has lead to the discovery of a new biomaterial, Gelrin™, which has been licensed to a company called Regentis Biomaterials Ltd., of which he is a founder. The technology transfer of the patented Gelrin biomaterial technology from the Technion into human clinical trials, which are currently underway in Europe, has been an integral part of his tenure in the department.

Seliktar has received several awards for his research and teaching accomplishments, including the Dudi Ben-Aharon Award for Excellence in Research, the Salomon and Simon Mani Award for Excellence in Teaching and the Hershel Rich Innovation Award. He currently serves as the Director of the Norman Seiden International Multidisciplinary Graduate program in Nanoscience & Nanotechnology. Seliktar was recently awarded a large-scale international cooperation grant from the Singapore government in the area of cardiac restoration therapies; he serves as the director and lead PI of this multi-national collaborative endeavour.